title: Activation of c-Abl kinase activity and transformation by a chemical inducer of dimerization.
abstract: c-Abl is a non-receptor tyrosine kinase that is activated in human leukemias by the fusion of Bcr or Tel sequences to the Abl NH(2) terminus. Although Bcr and Tel have little in common, both contain oligomerization domains. To determine whether oligomerization alone is sufficient to activate c-Abl, we have generated and characterized an Abl protein that can be activated selectively with the chemical inducer of dimerization, AP1510. Mutant Abl proteins with one (c4F1) or two (c4F2) copies of the AP1510 binding motif (FKBP) transformed NIH 3T3 cells in a ligand-dependent manner with the c4F2 protein 60-fold more potent than c4F1. Both chimeric proteins exhibited ligand-dependent dimerization in vivo, suggesting that the increased transformation efficiency of the c4F2 mutant reflects more effective dimerization rather than formation of higher order oligomers. In the absence of ligand, c4F2-expresssing fibroblasts morphologically reverted and arrested in G(1). In Ba/F3 cells, the c4F2 chimera exhibited ligand-dependent kinase activation, transformation to interleukin 3-independent growth, and relocalization of the fusion protein from nucleus to cytoplasm. These results demonstrate that dimerization alone is sufficient to activate the Abl kinase and provide a method to regulate conditionally c-Abl activity that will be useful for studying the normal physiological role of c-Abl and the mechanism of transformation and leukemogenesis.
authors.affiliation: Center for Blood Research, Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115-5717, USA.
authors.forename: K M
authors.initials: KM
authors.lastname: Smith
authors.forename: R A
authors.initials: RA
authors.lastname: Van Etten
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001773:Blood Cells / Q000166:cytology / Q000201:enzymology; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D003432:Cross-Linking Reagents / Q000494:pharmacology*; D019281:Dimerization; D004789:Enzyme Activation; D005347:Fibroblasts / Q000166:cytology / Q000201:enzymology; D006801:Humans; D051379:Mice; D010766:Phosphorylation; D016315:Proto-Oncogene Proteins c-abl / Q000235:genetics / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D016559:Tacrolimus / Q000031:analogs & derivatives / Q000494:pharmacology*; D022021:Tacrolimus Binding Proteins / Q000235:genetics
chemical_list: C119717:AP 1510; D003432:Cross-Linking Reagents; D011993:Recombinant Fusion Proteins; D016315:Proto-Oncogene Proteins c-abl; D022021:Tacrolimus Binding Proteins; D016559:Tacrolimus